x

Like our Facebook Page

   
Early Times Newspaper Jammu, Leading Newspaper Jammu
 
Breaking News :   Striking Balance | BJP ‘poster-boy’ unlikely to contest as rebel candidate | Candidates worried as Jammu-Reasi seat witnesses dull campaign | Azad hits out at Omar Abdullah | LG Sinha attends Utthan foundation’s symposium on Sanatan culture | Sajjad Lone meets Muzaffar Baig, seeks support to win Bla LS seat | Secular forces in Jammu rally against divisive politics: Sadhotra | Jammu: Over 17.80 lakh voters to decide fate of 22 candidates | DPAP contesting LS elections independently: Azad | Lashkar terrorist behind Govt employee’s killing: Police | ADGP Jammu conducted security review meeting at Reasi | 67 suspects detained | J&K Police urge vigilance against unauthorized social media posts featuring officers | Nitin Gadkari faints while speaking at campaign rally | Emergency procurement powers help Army to modernise itself: General Manoj Pande | 15 flights diverted from Delhi due to bad weather conditions | No action for short deduction of TDS if PAN linked with Aadhaar by May 31 | "Modi's Guarantee Is Global", says S Jaishankar | Encounter underway | Lightest bulletproof jacket | Voting for BJP means supporting patriots who want to establish 'Ram Rajya' in country: Shah | Govt official dismissed | School timing changed | Kavinder pitches for PM Modi's third term to continue India's development trail | DC Kupwara kick-starts plantation drive at PS Wadder Payeen | REC Ltd to extend term loan of Rs 1,869 Crores for Kiru HEP | Auction for Telecom Spectrum to continue, Administrative Allocation Limited: Report | DRI seizes valuables of Rs 10.48 Cr after busting gold smuggling syndicate in Mumbai; 4 held | Border Road Organisation opens Leh-Manali National Highway | Congress, its coalition aiming to loot income, savings, assets: BJP | BJP's communal narrative weakening national unity: Rattan Lal | Health Secretary reviews arrangements for Shri Amarnathji Yatra | Flag march conducted in Samba town ahead of second phase of Parliamentary elections | Medical health check up drive launched in GRP Jammu | DIG Udhampur-Reasi range conducted GELS-24 review meeting cum briefing session | Notorious criminal slapped PSA by police | Police foils bovine smuggling bid, arrests 2 smugglers | Cybercrime investigation unit recovers online defrauded amount | Navi Mumbai cops trace stray dog seen in CCTV footage to crack ragpicker's murder case | Breakthrough in Rajouri attack emerges | 16 chronic drug peddlers booked, lodged in jail | CUJ organizes corporate connect "Parshikshan Pe Samvad" 2024 | GDC Khour organizes an Awareness Lecture | Panchayat Diwas celebrated in National College of Education | Jodhamal organizes ICARUS'24: A Drone War Competition | Govt College for Women, Bhagwati Nagar organizes Quiz Competition | GDC Vijaypur organizes plantation drive | Empowering Adolescents: Addressing substance abuse and mental health | Electoral Literacy Club in collaboration with | YCET's students placed in KodNest Technologies Pvt Ltd | GDC Samba organizes a vibrant and educational Mock Parliament | Back Issues  
 
news details
Forest fire triggers mine blasts along LoC in Poonch
10/24/2020 12:44:00 AM

EARLY TIMES REPORT

POONCH, Oct, 23: Aforest fire triggered several mine blasts along the Line of Control in Jammu and Kashmir’s Poonch district on Friday, officials said. The fire broke out in Balakot sector and spread to few adjoining areas, they said. Some anti-personnel mines exploded due to the fire, triggering panic among the residents, the officials said. The blaze was brought under control by Army and forest department personnel within a few hours, they said. The Bharat Biotech will be conducting Phase 3 trials for its Covid-19 vaccine candidate, COVAXIN, in 25 centres across India and a total of 26,000 people will be participating in the Phase 3 trials.
The Drug Controller General of India (DGCI) has already granted Bharat Biotech a go ahead for the Phase 3 trials after successful completion of Phase 1 and 2 clinical trials. However, the permission for the Phase 3 trials of COVAXIN is subject to minor changes in the primary efficacy endpoint for the symptomatic cases. The primary efficacy endpoint is the outcome by which the effectiveness of treatments in a clinical trial is evaluated. A carefully chosen endpoint can ensure no bias. A primary efficacy endpoint needs to be specified before the start of the clinical trial. “The firm has presented their data from Phase I and II along with animal challenge data in two species including NHP on the Inactivated Corona Virus Vaccine (BBV152) along with the proposal to conduct event-driven Phase III clinical trial to assess the efficacy of the vaccine,” the expert panel of Subject Expert Committee (SEC) said. Developed by Bharat Biotech along with the Indian Council of Medical Research and National Institute of Virology, Covaxin was India’s first indigenous vaccine candidate against the Covid-19.
  Share This News with Your Friends on Social Network  
  Comment on this Story  
 
 
 
Early Times Android App
STOCK UPDATE
  
BSE Sensex
NSE Nifty
 
CRICKET UPDATE
 
 
 
 
 
 
 
 
   
Home About Us Top Stories Local News National News Sports News Opinion Editorial ET Cetra Advertise with Us ET E-paper
 
 
J&K RELATED WEBSITES
J&K Govt. Official website
Jammu Kashmir Tourism
JKTDC
Mata Vaishnodevi Shrine Board
Shri Amarnath Ji Shrine Board
Shri Shiv Khori Shrine Board
UTILITY
Train Enquiry
IRCTC
Matavaishnodevi
BSNL
Jammu Kashmir Bank
State Bank of India
PUBLIC INTEREST
Passport Department
Income Tax Department
JK CAMPA
JK GAD
IT Education
Web Site Design Services
EDUCATION
Jammu University
Jammu University Results
JKBOSE
Kashmir University
IGNOU Jammu Center
SMVDU